160 million! Yiyi Pharmaceutical intends to buy a house from the real controller and other people to build an orthopaedic hospital

The property purchased by the actual controller of 72 million yuan is now going to be "reverse" to the listed company at a price of 162 million yuan. On November 13th, Yiyi Pharmaceuticals announced that its wholly-owned subsidiary Yiyi Investment intends to invest 162 million yuan to acquire six properties under the name of controlling shareholders, actual controllers, chairman Du Yuling and concerted actors, company directors and senior managers.
As of September 30, 2018, the evaluation benchmark date, Ms. Dou and Ms. Du had declared a total purchase value of 72 million yuan for six commercial housing units, and if sold at a price of 162 million yuan, Ms. Dou and Ms. Dou would earn $90 million. Yiyi Pharmaceuticals acquired the property for the construction of orthopaedic hospitals, but the company's past business focus has been on tumors, cardiovascular and other fields.The real controller and other real estate sales can earn 90 million
Yiyi Pharmaceuticals announced that the company's wholly-owned subsidiary Yiyi Investment intends to invest 162 million yuan to buy the controlling shareholder, the actual controller, chairman Du Yuling and concerted actors, company directors, senior management Du Yaqi under the name of six properties.
the above six properties are located in Guiyang City, Guanshan Lake District, Jinyang South Road, 298 Ruili uptown, are commercial housing, planning purposes for the operation of office use, a total construction area of 8220.15 square meters. Among them, the largest single commercial housing construction area reached 1769.22 square meters, the smallest construction area also reached 873.22 square meters.
sold six properties to listed companies for 162 million yuan, and Mr. Du and Ms. Du made a fortune, earning $90 million.
disclosed that as of September 30, 2018, the benchmark date for evaluation, Dou Yuling and Dou Yaqi declared the purchase amount of six sets of commercial housing assets totalling 72 million yuan. According to the building area of 8220.15 square meters, the average purchase price is 8759 yuan / square meters. Based on the purchase price of 162 million yuan, Yiyi Investment was purchased at an average price of nearly 20,000 yuan per square meter.
reporter noted that Yiyi Pharmaceuticals this announcement did not introduce the real controller and other specific time to buy a house.used as an orthopaedic hospital construction
from the real controller to buy a building area of 8220.15 square meters of real estate, Yiyi Pharmaceutical said that the move is intended to invest in the establishment of a private orthopaedic specialist hospital, in order to meet the needs of hospital operations. The company also stressed that the investment in the new private orthopaedic specialist hospital in line with the company's active expansion of the strategic direction of medical services, after investigation and evaluation, the location of the property, area, building structure and other suitable for the construction of the hospital, the purchase of the property can reduce the construction cycle, speed up the hospital into operation process, to avoid rental property to bring future rent increases or can not renew the risk.
the strategy of investing in the establishment of private orthopaedic specialist hospitals seems to have been somewhat sudden, with little mention of the development of orthopaedic specialist hospitals mentioned in its past strategic statements.
Yiyi Pharmaceuticals is a new drug research, development, production and sales of high-tech enterprises, its focus on cancer, cardiovascular, gynecology and other therapeutic fields of drug production and sales, orthopaedic drugs the main products for the golden bone lotus capsules. In the operating composition of listed companies in 2017, the prescription drug business achieved operating income of 2.955 billion yuan, accounting for 77.63 percent of current operating income. In its regular reporting business description, the company has always emphasized that the core market is still in areas such as anti-tumor drugs.
, Yiyi Pharmaceuticals is not satisfied with the single identity of pharmaceutical companies, has long expressed strong interest in hospital-type medical services, and focused on cancer hospitals. According to its 2017 semi-annual report, the company cooperates with hospitals to build oncology treatment centers and set up oncologist groups, and has approved 1,380 beds at several hospitals, including Minnan Hospital, Chaoyang Hospital and Bi festival hospital. In its 2017 Annual Report, Yiyi Pharmaceuticals mentioned the creation of an oncology medical service platform for the General Hospital-Oncology Treatment Center-Oncologist Group.
2017, Yiyi Pharmaceuticals' medical services revenue increased significantly from 496 million yuan to 719 million yuan, and its share of operating income increased from 13.45 percent to 18.87 percent.
outside the oncology hospital, why did Yiyi Pharmaceutical suddenly think of developing a private orthopaedic hospital? On November 13th, the reporter called Yiyi Pharmaceutical Securities Department, and the relevant person said that Dong was out on business. The reporter then sent out an outline of the interview and questions, but could not get a reply. (Daily Economic News)